These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10049277)

  • 1. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria.
    Kashuba AD; Nafziger AN; Drusano GL; Bertino JS
    Antimicrob Agents Chemother; 1999 Mar; 43(3):623-9. PubMed ID: 10049277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms.
    Kashuba AD; Bertino JS; Nafziger AN
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1842-4. PubMed ID: 9661031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
    Bland CM; Pai MP; Lodise TP
    Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline.
    Bhavnani SM; Rubino CM; Hammel JP; Forrest A; Dartois N; Cooper CA; Korth-Bradley J; Ambrose PG
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1065-72. PubMed ID: 22143524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.
    Arnold A; Brouse SD; Pitcher WD; Hall RG
    J Intensive Care Med; 2010 Sep; 25(5):259-70. PubMed ID: 20622257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
    Ereshefsky BJ; Al-Hasan MN; Gokun Y; Martin CA
    J Chemother; 2017 Feb; 29(1):30-37. PubMed ID: 27376664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
    Martínez B; Gómez J; Gómez Vargas J; Gómez JR; Baños V; Sánchez ME; Canteras M; Valdés M
    Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients.
    Crabtree TD; Pelletier SJ; Gleason TG; Pruett TL; Sawyer RG
    Arch Surg; 1999 Dec; 134(12):1293-8; discussion 1298-9. PubMed ID: 10593326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic dosing for multidrug-resistant pathogen pneumonia.
    Abdul-Aziz MH; Lipman J; Roberts JA
    Curr Opin Infect Dis; 2017 Apr; 30(2):231-239. PubMed ID: 28030371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of twice-daily cefotaxime in the treatment of hospitalized patients with severe infections.
    Keller C
    Diagn Microbiol Infect Dis; 1995; 22(1-2):159-61. PubMed ID: 7587032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia.
    Muller AE; Punt N; Mouton JW
    J Antimicrob Chemother; 2013 Apr; 68(4):900-6. PubMed ID: 23190766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y; Jin L; Liu N; Luo X; Dong D; Tang J; Wang Y; You Y; Liu Y; Chen M; Yu Z; Hao Y; Gu Q
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing mortality in hospital-acquired pneumonia caused by Gram-negative bacteria in China.
    Feng DY; Zhou YQ; Zou XL; Zhou M; Wu WB; Chen XX; Wang YH; Zhang TT
    J Infect Public Health; 2019; 12(5):630-633. PubMed ID: 30824328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
    J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.
    Heffernan AJ; Sime FB; Lipman J; Dhanani J; Andrews K; Ellwood D; Grimwood K; Roberts JA
    Int J Antimicrob Agents; 2019 Mar; 53(3):234-245. PubMed ID: 30472292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.